IBM’s, Budget

IBM’s Budget Cannibalization: When AI Hardware Eats Software’s Lunch

Published on 07/27/2026 at 14:21 | Redaktion boerse-global.de

IBM's worst trading day since 1968 reveals a budget shift from high-margin software to AI hardware, with mainframe sales down 42% but deferred deals closing.

IBM Stock Plunges 25% as AI Spending Cannibalizes Software Revenue
IBM’s Budget Cannibalization: When AI Hardware Eats Software’s Lunch Illustration mit AI erstellt übermittelt durch boerse-global.de

The arithmetic of enterprise IT spending has turned brutal for IBM. Every dollar a customer pours into AI-ready servers and storage is a dollar that isn’t flowing into the high-margin software deals the company was banking on. That internal tug-of-war — not a sudden loss of competitive relevance — is what has shredded the stock and left investors debating whether this is a buying opportunity or a value trap.

The 25% Plunge That Rewrote History

July 14 delivered IBM’s worst single trading session since 1968. The stock cratered 25% in a single day after preliminary second-quarter numbers missed expectations. When the final results landed on July 22, they confirmed the damage: no fresh surprises, but no relief either. The company also trimmed its 2026 growth forecast on a constant-currency basis.

The carnage was concentrated in the infrastructure segment. Mainframe sales under the System z brand collapsed 42% year-over-year — a stunning reversal for what had long been IBM’s most predictable revenue engine. Even loyal enterprise customers are reallocating budgets, squeezing the legacy hardware cycle that once funded the software ecosystem layered on top.

The stock hit a 52-week low of €175.14 on July 23 before recovering to €190.24, a gain of roughly 8% from the trough. But that still leaves it 35% below the June high of €292.85. Year-to-date, the shares are down 27.66%; the 30-day loss stands at 21.13%.

Should investors sell immediately? Or is it worth buying IBM?

The Volatility of a Century-Old Blue Chip

With an annualized volatility reading above 85% over the past 30 days, IBM is trading more like a speculative growth stock than a defensive value play. The relative strength index sits at 35.3 — deep in oversold territory, though not as extreme as the low-to-mid-20s readings seen immediately after the July crash. The technical picture suggests the selling has been aggressive enough to leave room for a countermove, but the path back to the 50-day moving average of €228.62 remains steep.

The “Delayed, Not Lost” Thesis

CEO Arvind Krishna has framed the mainframe weakness as a timing problem, not a structural one. Customers are front-loading hardware purchases — distributed infrastructure, including Power systems and storage, surged 37% in the quarter — while pushing software commitments into later periods. Crucially, management reports that roughly one-third of the deferred deals have already closed in the third quarter.

CFO Jim Kavanaugh was even more direct on the mainframe question: “We see no evidence that customers are migrating away from the mainframe.” The company expects significant strength in the program during the second half of the year.

Independent analysts largely agree the sell-off was overdone. One enterprise-sector research director called the 25% post-earnings drop excessive — a reflection of an unusually volatile market and uncertainty about how quickly AI investments will generate returns, rather than a fundamental breakdown in IBM’s business model.

The Catch: Three Dollars of Software for Every Dollar of Hardware

The bull case rests on a simple multiplier. For every dollar of mainframe hardware IBM sells, it typically generates three dollars in attached software revenue. A prolonged mainframe pause doesn’t just hurt the infrastructure line — it starves the higher-margin software business that is supposed to drive IBM’s future growth.

And that software business is already showing strain. It grew only modestly in the quarter and missed its own targets, while the consulting division essentially flatlined. This isn’t a single weak spot; it’s a slowdown across multiple fronts, all tied back to the same budget cannibalization.

IBM at a turning point? This analysis reveals what investors need to know now.

The consensus analyst price target of €231.06 implies upside of roughly 22.9% from current levels. That gap reflects genuine skepticism, not blind conviction in a rapid recovery. The stock would need a real shift in enterprise spending patterns — away from hardware hunger and back toward software and cloud investments — to make that target achievable.

What the Market Is Pricing In

The current share price embeds a scenario where the mainframe weakness proves structural, not cyclical. If management’s “delayed, not lost” narrative holds through the second half of the year, the deep oversold conditions and wide distance from the 52-week high could fuel a stronger rebound than the market currently expects.

But the risk is real. Another weak quarter on the mainframe or software side would validate the bears and could drive the stock to new lows rather than toward analyst targets. For now, IBM is a bet on timing — that enterprise budgets will eventually rotate back from hardware to software, and that the company’s century-old franchise still has the pricing power to capture that shift when it comes.

Ad

IBM Stock: New Analysis - 27 July

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4592001014 | IBM’S | boerse | 69884933 |